BMED holdings: all 56 positions
BMED held 56 positions as of Oct 13, 2026. Moderna is the largest at 5.55%; the top 10 are 43.5% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | Moderna | MRNA | 5.55% |
| 2 | Gilead Sciences | GILD | 5.50% |
| 3 | Danaher | DHR | 5.32% |
| 4 | Abbvie | ABBV | 4.93% |
| 5 | Thermo Fisher Scientific Inc | TMO | 4.42% |
| 6 | Iqvia Holdings Inc | IQV | 3.70% |
| 7 | Waters Corp | WAT | 3.65% |
| 8 | Biogen | BIIB | 3.64% |
| 9 | Mettler Toledo | MTD | 3.59% |
| 10 | Vertex Pharmaceuticals | VRTX | 3.17% |
| 11 | Merck & Co Inc | MRK | 3.09% |
| 12 | Edwards Lifesciences | EW | 2.98% |
| 13 | Roche Ps Par AG | ROP | 2.72% |
| 14 | Amgen Inc | AMGN | 2.45% |
| 15 | Dexcom Inc | DXCM | 2.44% |
| 16 | Illumina Inc | ILMN | 2.24% |
| 17 | Johnson & Johnson | JNJ | 2.11% |
| 18 | Halozyme Therapeutics | HALO | 2.05% |
| 19 | Genmab Sponsored ADR | GMAB | 1.95% |
| 20 | Novartis AG | NOVN | 1.86% |
| 21 | Argenx SE ADR | ARGX | 1.64% |
| 22 | Pfizer | PFE | 1.54% |
| 23 | Charles River Laboratories Interna | CRL | 1.52% |
| 24 | Wuxi Biologics Cayman | 1.40% | |
| 25 | Guardant Health | GH | 1.40% |
| 26 | Neurocrine Biosciences | NBIX | 1.38% |
| 27 | Galderma Group N AG | GALD | 1.33% |
| 28 | Abbott Laboratories | ABT | 1.32% |
| 29 | Cytokinetics | CYTK | 1.31% |
| 30 | Bristol Myers Squibb | BMY | 1.28% |
| 31 | Roivant Sciences Ltd | ROIV | 1.27% |
| 32 | Agilent Technologies Inc | A | 1.26% |
| 33 | Cencora | COR | 1.02% |
| 34 | Biomarin Pharmaceutical | BMRN | 1.02% |
| 35 | Protagonist Therapeutics | PTGX | 0.89% |
| 36 | Tempus Ai Class A | TEM | 0.88% |
| 37 | Axsome Therapeutics | AXSM | 0.83% |
| 38 | Bruker | BRKR | 0.68% |
| 39 | UCB SA | UCB | 0.61% |
| 40 | Revolution Medicines | RVMD | 0.58% |
| 41 | Alkermes | ALKS | 0.56% |
| 42 | PTC Therapeutics | PTCT | 0.44% |
| 43 | Dianthus Therapeutics Inc | DNTH | 0.41% |
| 44 | MBX Biosciences | MBX | 0.40% |
| 45 | Cogent Biosciences | COGT | 0.38% |
| 46 | Incyte Corp | INCY | 0.29% |
| 47 | Viridian Therapeutics Ors | VRDN | 0.27% |
| 48 | Sagimet Biosciences Series A | SGMT | 0.11% |
| 49 | Summit Therapeutics | SMMT | 0.08% |
| 50 | Avalo Therapeutics | AVTX | 0.08% |
| 51 | Eikon Therapeutics | EIKN | 0.07% |
| 52 | Abiomed Cvrs | 0.00% | |
| 53 | Mirati Therapeutics Inc | MRTX | 0.00% |
| 54 | Blueprint Medicines Corp | 0.00% | |
| 55 | Vigil Neuroscience Inc Cvr | DUMMY | 0.00% |
| 56 | Korro Bio Inc Cvr | KRRBIO | 0.00% |
| BLK Csh Fnd Treasury Sl Agency | 5.47% | ||
| USD Cash | 0.91% | ||
| GBP Cash | 0.00% | ||
| HKD Cash | 0.00% | ||
| KRW Cash | 0.00% | ||
| Cash and other net assets | 0.01% |
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of BMED, data as of Oct 13, 2026. https://etfiq.com/funds/bmed/holdings/
ETFIQ. (Oct 13, 2026). Holdings of BMED. Retrieved from https://etfiq.com/funds/bmed/holdings/
[Holdings of BMED (ETFIQ, Oct 13, 2026)](https://etfiq.com/funds/bmed/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.